A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status

Critical Care Medicine

Volumn 37, Issue 6, 2009, Pages 2018-2024

  Morgera, Stanislao ^a   Schneider, Michael ^a   Slowinski, Torsten ^a   Vargas Hein, Ortrud ^a   Zuckermann Becker, Heidrun ^a   Peters, Harm ^a   Kindgen Milles, Detlef ^b   Neumayer, Hans Hellmut ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Acid base control; Continuous venovenous hemodialysis; Hemofilter lifetime; Hypercalcemia; Regional anticoagulation with citrate; Treatment dose

Indexed keywords

CALCIUM; CITRIC ACID; ANTICOAGULANT AGENT; CITRATE TRISODIUM;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD FLOW; BODY WEIGHT; CONTROLLED STUDY; DIALYSATE; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; CLINICAL PROTOCOL; DRUG EFFECT; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY;

ACID-BASE EQUILIBRIUM; AGED; ANTICOAGULANTS; CITRATES; CLINICAL PROTOCOLS; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 66449112268     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181a00a92     Document Type: Article

References (20)

1. Oudemans-Van Straaten HM, Wester JP, de Pont AC, et al: Anticoagulation strategies in continuous renal replacement therapy: Can the choice be evidence based? Intensive Care Med 2006; 32:188-202
2. Pinnick RV, Wiegmann TB, Diederich DA: Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 1983; 308:258-261
3. Mehta RL, McDonald BR, Aguilar MM, et al: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990; 38:976-981
4. Mehta RL, McDonald BR, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis. An update after 12 months. Contrib Nephrol 1991; 93:210-214
5. Ward DM, Mehta RL: Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int 1993; 43(Suppl 41):237-244
6. Morgera S, Scholle C, Voss G, et al: Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: Single-center experience. Nephron Clin Pract 2004; 97:cl31-cl36
7. Ronco C, Bellomo R, Homel P, et al: Effects of different doses in continuous veno-venous haemonltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000; 356:26-30
8. Morgera S, Haase M, Ruckert M, et al: Regional citrate anticoagulation in continuous hemodialysis-acid-base and electrolyte balance at an increased dose of dialysis. Nephron Clin Pract 2005; 101:c211-c219
9. Tolwani AJ, Prendergast MB, Speer RR, et al: A practical citrate anticoagulation continuous venovenous hemodianltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol 2006; 1:79-87
10. Singer MA, Morton AR: Mouse to elephant: Biological scaling and Kt/V. Am J Kidney Dis 2000; 35:306-309
11. Chadha V, Garg U, Warady BA, et al: Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol 2002; 17:819-824
12. Zobel G, Rödl S, Urlesberger B, et al: Continuous renal replacement therapy in critically ill patients. Kidney Int Suppl 1998; 6&S169-S173
13. Livingston EH, Lee S: Body surface area prediction in normal-weight and obese patients. Am J Physiol Endocrinol Metab 2001; 28LE586-E591
14. Rocktaschel J, Morimatsu H, Uchino S, et al: Impact of continuous veno-venous hemonl-tration on acid-base balance. Int J Artif Organs 2003; 26:19-25
15. Kindgen-Milles D, Amman J, Kleinekofort W, et al: Treatment of metabolic alkalosis during continuous renal replacement therapy with regional citrate anticoagulation. Int J Artif Organs 2008; 31:363-366
16. Monchi M, Berghmans D, Ledoux D, et al: Citrate vs. heparin for anticoagulation in continuous venovenous hemonltration: A prospective randomized study. Intensive Care Med 2004; 30:260-265
17. Kutsogiannis DJ, Gibney RT, Stollery D, et al: Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005; 67:2361-2367
18. Mulder J, Tan HK, Bellomo R, et al: Platelet loss across the hemonlter during continuous hemo-filtration. Int J Artif Organs 2003; 26:906-912
19. Meier-Kriesche HU, Gitomer J, Finkel K, et al: Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001; 29:748-752
20. Saudan P, Niederberger M, De Seigneux S, et al: Adding a dialysis dose to continuous hemonltration increases survival in patients with acute renal failure. Kidney Int 2006; 70:1312-1317